Vimarsana
Biggest News Aggregation in the World

Page 35 - Thomas Triomphe News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Thomas Triomphe. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Thomas Triomphe Today - Breaking & Trending Today

Sanofi's €10B sales target for Dupixent? The 'megabrand' is more than halfway there, exec says - Vimarsana News

Sanofi's €10B sales target for Dupixent? The 'megabrand' is more than halfway there, exec says

Shortly after Sanofi CEO Paul Hudson joined the company in 2019, he laid out an ambition to invest as much as necessary to turn the Regeneron-partnered antibody drug Dupixent into a megablockbuster. Two years later, Sanofi is well on its way.

How the world can be more prepared for the next pandemic - Vimarsana News

How the world can be more prepared for the next pandemic

How the world can be more prepared for the next pandemic

How the French bid for a Covid vaccine champion fell apart - Vimarsana News

How the French bid for a Covid vaccine champion fell apart

Sanofi's jab worked and was France's best shot at an mRNA vaccine - but it was simply too late

Coronablog: reproductiegetal stijgt boven 1 - België - Vimarsana News

Coronablog: reproductiegetal stijgt boven 1 - België

Blijf in deze live op de hoogte van onze laatste updates over de coronacrisis.

Source: knack.be
Sanofi suspenderá desarrollo de vacuna de ARN mensajero contra COVID-19 - Vimarsana News

Sanofi suspenderá desarrollo de vacuna de ARN mensajero contra COVID-19

El laboratorio francés proseguirá con su otra vacuna, basada en una proteína recombinante.